Reducing the impact of pain in the youngest children: Q&A with Dr. Manon Ranger

News

Posted on

The first few weeks after a preterm baby is born are critical.

Infants in the neonatal intensive care unit (NICU) need to have blood tests and stressful interventions to keep them healthy. However, many of these life-saving medical procedures can also be painful and induce stress in these young babies, which can have lasting effects on brain development.

Dr. Manon Ranger has recently returned to BC Children’s Hospital and UBC to study whether we can develop new ways to reduce the impact of this early life stress.

Her research will be carried out at the BC Women’s Hospital + Health Centre NICU and the Centre for Molecular Medicine and Therapeutics (CMMT) at BC Children’s Hospital Research Institute. She is an assistant Professor at the School of Nursing at the University of British Columbia (UBC).

We spoke to Dr. Ranger about her work and how the treatment of pain in young children has changed over the years.

What got you started on this path?

In the 1970s and 80s the medical community believed babies’ brains weren’t developed enough to feel pain, especially if they were born weeks or months early.

When I was finishing my nursing degree at the University of Montreal in the 1990s, this paradigm was beginning to shift. Researchers were realizing that young babies do feel pain and that early life pain could impact their development. I became fascinated with the ongoing debate about how we should be caring for our very youngest children.

I first dipped my toes into the academic world when I began a masters in nursing at the University of Montreal. While there, I studied whether nurses had the necessary tools to assess and manage pain in the hospital. I loved being able to combine my passion for nursing with research to better care for our patients.

This newfound interest convinced me to pursue a PhD examining how to assess pain in infants. While my previous work involved managing pain in children as a clinical nurse specialist for the acute pain service at the Montreal Children’s Hospital, assessing pain in preterm infants is much more challenging. Some of these tiny patients can’t even cry properly, let alone tell a clinician what’s wrong. Today, there are over 40 different methods for assessing pain in infants, and yet nurses and doctors in neonatal intensive care units still struggle to recognize and properly treat it.

It’s now become my life’s work to understand how best to nurture the healthy development of preterm babies and to alleviate their pain as much as possible.

How can we assess the effect of pain in preterm infants?

One way to determine the impacts is through longer term studies. Dr. Ruth Grunau, whose team I joined as a UBC postdoctoral fellow from 2012 to 2016, followed very preterm children who were admitted at the BC Women’s NICU for up to 8 years. The team kept track of the skin-breaking procedures babies received while in the NICU, such as blood draws, and conducted developmental and neuroimaging tests at various time points until the children were school age. We were able to show that the pain-related stress from these life-saving medical procedures could affect brain development and were linked, among others, to anxious behaviours later in life.

There is still a lot of work to do to fully understand the impact of care and how we can do better. As a new investigator at BC Children’s, I will work to find out how we can reduce the harms of these necessary procedures.

What will your research at UBC and BC Children’s entail?

I will be blending basic science models in the CMMT with clinical research in the hospital to improve our understanding of pain-related stress in preterm infants.

When children are born several weeks early their immune system is usually under-developed, so they often acquire infections and undergo treatments which may have long-term effects on their development. As a result, it can be difficult for parents to hold their babies at this time, separating them both physically and emotionally. It’s important that studies in the lab help us understand how these factors interact and contribute to a baby’s growth.

What are your hopes for the future?

I would like to connect pain, infection, treatments, and parental connection in a unified theory that can guide how nurses and doctors can best treat and nurture preterm infants in intensive care.

I believe it’s vitally important that advances in neonatal care include a balanced approach of stress reduction and pain management to give these infants the best possible start in life.

I look forward to working with the fantastic researchers and clinical teams at BC Children’s Hospital to help protect our most vulnerable patients.

Alan Worsley
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • children playing outdoors
    News

    Billions of doses later, global review confirms mRNA vaccines are safe

    A sweeping global review research has found that mRNA vaccines are safe and highly effective at preventing infectious diseases, such as COVID-19. These vaccines also have potential applications for a range of other diseases, including influenza, respiratory syncytial virus (RSV), cancer, and autoimmune disorders.

    Read more
  • Young child holding their head
    News

    Emerging treatment options offer hope to children affected by migraine

    Headache disorders, such as migraine, can drastically disrupt daily life. Still, they are underestimated, underrecognized, and undertreated. Migraine is among the top three causes of disability in individuals aged 10 to 24, with 10 per cent of children experiencing it before reaching puberty. Migraine is associated with school absenteeism, disengagement from extracurricular activities, and decreased…

    Read more
  • News

    Gut fungi may hold the key to treating asthma, allergies worldwide

    Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may be promising targets for new therapies.

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now